DC Chemicals

All products / DC8493

NVP-LDE225(Erismodegib)
CAT. NO. DC8493

NVP-LDE225(Erismodegib)

Pack sizes and prices

Pack sizePrice
100 mg$300 USDRequest a quote →
250 mg$600 USDRequest a quote →
1 g$1,200 USDRequest a quote →

In stock. Contact our team for lead time, shipping and final quotation.

Product overview

Erismodegib (LDE225) is a potent and selective Smoothened (Smo) antagonist with IC50s of 1.3 nM and 2.5 nM for mouse and human Smo, respectively.

For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.

Identity and specifications

Catalog numberDC8493
Product nameNVP-LDE225(Erismodegib)
CAS956697-53-3
Molecular formulaC26H26F3N3O3
Molecular weight485.498
Purity>98%
SMILESFC(OC1C([H])=C([H])C(=C([H])C=1[H])C1C([H])=C([H])C([H])=C(C(N([H])C2=C([H])N=C(C([H])=C2[H])N2C([H])([H])[C@]([H])(C([H])([H])[H])O[C@]([H])(C([H])([H])[H])C2([H])[H])=O)C=1C([H])([H])[H])(F)F

Source-listed specifications; the batch COA applies.

Source and product documents

The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.

DC Chemicals — NVP-LDE225(Erismodegib) (DC8493)

Source references

[1]. Pan S, et al. Discovery of NVP-LDE225, a Potent and Selective Smoothened Antagonist. ACS Med Chem Lett. 2010 Mar 16;1(3):130-4. [2]. Irvine DA, et al. Deregulated hedgehog pathway signaling is inhibited by the smoothened antagonist LDE225 (Sonidegib) in chronic phase chronic myeloid leukaemia. Sci Rep. 2016 May 9;6:25476.

Related research products